2 天
Verywell Health on MSNA New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer TypeFact checked by Nick Blackmer The Food and Drug Administration (FDA) recently approved a new targeted chemotherapy drug for ...
The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...
A new treatment for colorectal cancer that has spread to the liver is showing promising results in Dutch medical trials. The ...
Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.
Many questions remain about the direct effect of chemotherapy on the brain, and the relationship between the doses of drug delivered to the brain and cognitive functioning. Given the current state ...
10 天
News Medical on MSNChemotherapy linked to persistent nerve pain in 4 in 10 cancer patientsWorldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...
Many patients are unaware that oral chemotherapy like Temozolomide is covered by health insurance policies due to special ...
Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.
Cancer drugs whose price reduction was announced in the Union budget are used in a minority of cases while many other chemotherapy drugs used more commonly still remain expensive, doctors said at a ...
Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...
Researchers from the National University of Singapore (NUS) have found that non-invasive magnetic pulses can enhance the ...
11 天
Asian News International on MSNDatar Cancer Genetics to Provide Groundbreaking Video-Enhanced Results of In-Vitro ...PRNewswire New Delhi [India] / London [UK] / Munich [Germany], January 28: Datar Cancer Genetics (DCG) has launched a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果